Summa Corp’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,404
Closed -$363K 78
2025
Q1
$363K Sell
9,404
-3,643
-28% -$144K 0.21% 47
2024
Q4
$495K Hold
13,047
0.24% 38
2024
Q3
$547K Hold
13,047
0.26% 34
2024
Q2
$533K Buy
+13,047
New +$519K 0.26% 33
2024
Q1
Sell
-13,047
Closed -$528K 60
2023
Q4
$528K Buy
+13,047
New +$498K 0.37% 31

Other funds holding BME

Summa Corp's BME Position: Q2 2025 in Review

Summa Corp sold out of BlackRock Health Sciences Trust (BME) in Q2 2025, closing a stake of 9,404 shares — an estimated $363K sold.

Summa Corp first reported a position in BME in Q4 2023 and held it in 5 quarters. The position peaked at $547K in Q3 2024. 72 funds tracked by Wall St. Rank hold BME as of Q2 2025.

  • Summa Corp reported no remaining BlackRock Health Sciences Trust position as of Q2 2025 after selling out during the quarter.
  • Summa Corp sold 9,404 BlackRock Health Sciences Trust shares in Q2 2025, an estimated $363K.
  • Summa Corp first reported a position in BlackRock Health Sciences Trust in Q4 2023 and held it in 5 quarters.
  • Summa Corp's BlackRock Health Sciences Trust position peaked at $547K in Q3 2024.
  • 72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2025.

Based on Summa Corp's 13F filing for Q2 2025, filed 25 Jul 2025.